Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1610.15
-29.15 (-1.78%)
< Home < Back

Crisil assigns ‘A1+’ rating to commercial paper of Sun Pharma

Date: 05-10-2017

Credit rating agency, Crisil has assigned ‘A1+’ rating to Commercial Paper of Sun Pharmaceutical Industries. The rating agency has also reaffirmed ratings of ‘AAA/Stable’ and ‘A1+’ on the long term and short term bank facilities of the company, respectively.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.